Skip to Content

Inotiv Inc NOTV

Morningstar Rating
$2.01 −0.03 (1.47%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NOTV is trading at a 565% premium.
Price
$2.02
Fair Value
$8.78
Uncertainty
Extreme
1-Star Price
$81.55
5-Star Price
$3.60
Economic Moat
Vpf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NOTV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.04
Day Range
$1.982.08
52-Week Range
$1.5111.42
Bid/Ask
$2.00 / $2.02
Market Cap
$52.20 Mil
Volume/Avg
61,949 / 427,084

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.09
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
2,055

Comparables

Valuation

Metric
NOTV
ACRS
VCYT
Price/Earnings (Normalized)
189.65
Price/Book Value
0.260.701.61
Price/Sales
0.093.194.59
Price/Cash Flow
31.92
Price/Earnings
NOTV
ACRS
VCYT

Financial Strength

Metric
NOTV
ACRS
VCYT
Quick Ratio
0.216.404.41
Current Ratio
0.376.745.00
Interest Coverage
−0.87−11,324.57
Quick Ratio
NOTV
ACRS
VCYT

Profitability

Metric
NOTV
ACRS
VCYT
Return on Assets (Normalized)
−4.47%−36.39%8.19%
Return on Equity (Normalized)
−14.78%−47.28%8.76%
Return on Invested Capital (Normalized)
0.13%−47.18%7.87%
Return on Assets
NOTV
ACRS
VCYT
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
JyscnvzgyhLlwn$210.8 Bil
Danaher Corp
DHR
DtwrzryhGrwkll$190.8 Bil
IQVIA Holdings Inc
IQV
SqpylchlTfndgjf$43.5 Bil
IDEXX Laboratories Inc
IDXX
ShpdmlfljJtyfs$38.8 Bil
Agilent Technologies Inc
A
JxqtksznqzVlqf$38.1 Bil
Mettler-Toledo International Inc
MTD
HqnlgywpgJvmqhn$29.1 Bil
Icon PLC
ICLR
CwvfqcmkKzfsjc$27.5 Bil
Illumina Inc
ILMN
PrscfkjnYkkvjp$18.4 Bil
Waters Corp
WAT
PtksfvxrmMlnzs$17.8 Bil
Labcorp Holdings Inc
LH
SvytxslsxMwpcdd$17.5 Bil

Sponsor Center